Redeye returns with a more in-depth take on the Q1 report. We make some estimate changes but nothing that affects our fair value range, and we point to the remaining gap to peers on EV/sales multiples, despite a strong share price momentum YTD.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

OssDsign Q1 - An accelerating turnaround

© Modular Finance, source Nordic Press Releases